Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01.04.03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01.11.21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 01.06.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01.03.18 |
Mats Blom
BRD | Director/Board Member | 59 | 01.04.17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01.04.03 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 2 240 245 | 2 220 245 ( 99,11 %) | 0 | 99,11 % |
Unternehmenskontakt
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.com![Straße Auris Medical Holding AG](https://cdn.zonebourse.com/static/address/17068135.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+16.73% | 123 Mrd. | |
+21.13% | 115 Mrd. | |
+18.05% | 25.85 Mrd. | |
-17.94% | 20.9 Mrd. | |
-16.24% | 16.52 Mrd. | |
-11.76% | 16.77 Mrd. | |
-44.45% | 15.56 Mrd. | |
+69.92% | 15.49 Mrd. | |
+1.41% | 13.45 Mrd. |